Neuromeka Co., Ltd.

Neuromeka Co., Ltd.

KKRX:348340
16,980.00
KRW
-220.00
(-1.28%)
-2,093.28EPS
520.42BMarket Cap
Nov 13Next Earn
Neuromeka Co., Ltd.
KRX:348340
(Korea Stock Exchange)

Recent

price

16,980.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KRW
14,838.34
37,807.99
8,675.97
1,821.58
3,048.92
676.78
787.32
1,430.78
1,007.34
942.79
Revenue per Share
-45,187.79
-112,785.13
-3,600.04
-3,705.72
-2,734.96
-568.96
-1,011.36
-948.67
-1,167.78
-2,084.53
Basic EPS, GAAP
-30,575.64
-76,234.81
-10,179.67
-1,933.39
-559.29
-785.53
-2,465.46
-2,022.33
-772.36
-1,254.55
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-286.24
-829.44
624
132.41
942.89
2,294.77
1,363.71
612.1
670.55
1,757.17
Book Value per Share
-286.31
-873.02
618.68
125.27
934.34
2,276.63
1,345.66
595.67
660.88
1,734.22
Tangible Book Value per Share
- -
- -
1
2
2
14
17
18
19
19
Basic Weighted Avg Shares
1,193
3,093
7,212
4,066
7,351
9,755
13,743
25,269
18,954
18,156
Sales/Revenue/Turnover
-134.64
-122.15
-72.16
-200.57
-40.93
-79.89
-107.88
-75.25
-78.38
-89.48
Operating Margin (%)
32
101
647
976
889
901
1,007
2,322
2,832
3,018
Depreciation Expense
-3,633
-9,226
-2,993
-8,271
-6,594
-8,201
-17,654
-16,755
-21,973
-40,144
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-304.53
-298.31
-41.49
-203.43
-89.7
-84.07
-128.45
-66.3
-115.93
-221.1
Profit Margin (%)
2,247
5,396
7,786
-468
13,596
35,331
5,023
-15,861
-31,031
-12,244
Working Capital
37
1,412
693
450
269
65
20,837
26,083
8,332
9,740
LT Debt
-4,725
-13,692
10,301
2,186
15,565
39,727
24,056
10,869
13,895
37,108
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
-132.48
-74.3
-29.66
-55.35
-95.95
-177.53
-146.78
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
45,193
27,943
39,276
LT Borrowings
8,100
7,720
9,595
LT Finance Leases
232
193
145
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
21
21
21
Market Capitalization
406,710
740,483
520,419

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
38,055
30,444
32,904
Cash, Cash Equivalents & STI
18,228
8,749
13,404
Accounts Receivable, Net
3,609
4,212
2,943
Inventories
8,826
10,172
10,025
Total Current Liabilities
69,086
33,628
45,148
Payables & Accruals
- -
- -
- -
ST Debt
45,193
27,943
39,276
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
140.18%
27.83%
Free Cash Flow
- -
174.93%
-59.31%
Net Income, GAAP
- -
29.08%
31.15%
Sales/Revenue/Turnover
- -
42.65%
-24.99%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,639
7,344
6,232
8,054
25,269
2025
3,172
3,440
4,474
7,869
18,954
2026
2,992
2,822
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-324.18
-13.13
-383.89
-227.6
-948.67
2025
-401.8
-243.59
-225.2
-301.64
-1,167.78
2026
-1,256.88
-242
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Neuromeka Co., Ltd. (348340.KQ) Neuromeka Co., Ltd. manufactures industrial robots and develops a Robot as a Service platform ecosystem centered on collaborative robots for manufacturing, food and beverage services, and media and art applications. The company offers collaborative robots (Indy series), co-industrial robots, mobile robots (Moby), and delta robots (Laser series); smart actuators, robot controllers, teach pendants, and vision solutions; robot software; standard tools; and robot platform and remote management services. Founded in 2013 and headquartered in Seoul, South Korea, with a manufacturing facility in Pohang, Neuromeka operates primarily in South Korea while pursuing U.S. market expansion through certifications and partnerships. In March 2025, Neuromeka secures a KRW 5 billion ($3.7 million) investment from DN Solutions DN Solutions Co., Ltd. and forms a strategic alliance to enhance machine tending solutions like COBOSOL for automated loading and unloading in machine tools. The company also signs an MOU with KEBA for joint industrial robot development, achieves triple ISO certification, attains NSF certification for U.S. entry with robotic frying solutions, and leads 2024 annual sales as South Korea's top 100% domestically produced collaborative robot provider with 19 models in its 2025 lineup.